ABCB5 |
Q2M3G0
|
ATP binding cassette subfamily B member 5
|
|
1.5E-37 |
0.623 |
0.538 |
ADAM10 |
O14672
|
ADAM metallopeptidase domain 10
|
|
1.00 |
0.489 |
0.846 |
AHR |
P35869
|
aryl hydrocarbon receptor
|
Transcription factor
|
1.00 |
0.410 |
0.923 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
ALOX15 |
P16050
|
arachidonate 15-lipoxygenase
|
Enzyme
|
1.1E-23 |
0.502 |
0.846 |
APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
ARHGAP24 |
Q8N264
|
Rho GTPase activating protein 24
|
|
3.9E-10 |
0.456 |
0.808 |
ASCL1 |
P50553
|
achaete-scute family bHLH transcription factor 1
|
Transcription factor
|
0.68 |
0.552 |
0.692 |
ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
ATOH1 |
Q92858
|
atonal bHLH transcription factor 1
|
Enzyme
|
1.8E-02 |
0.633 |
0.500 |
AXIN1 |
O15169
|
axin 1
|
|
0.41 |
0.559 |
0.577 |
AXIN2 |
Q9Y2T1
|
axin 2
|
|
0.57 |
0.507 |
0.692 |
BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
BCC1 |
|
Basal cell carcinoma, susceptibility to, 1
|
|
|
0.890 |
0.115 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BIRC5 |
O15392
|
baculoviral IAP repeat containing 5
|
Enzyme modulator
|
5.6E-02 |
0.495 |
0.731 |
BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BRD4 |
O60885
|
bromodomain containing 4
|
Epigenetic regulator
|
1.00 |
0.446 |
0.885 |
C17orf97 |
Q6ZQX7
|
chromosome 17 open reading frame 97
|
|
4.8E-06 |
0.548 |
0.577 |
CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
CCDC54 |
Q8NEL0
|
coiled-coil domain containing 54
|
|
1.1E-10 |
0.659 |
0.500 |
CCHCR1 |
Q8TD31
|
coiled-coil alpha-helical rod protein 1
|
|
1.0E-16 |
0.505 |
0.808 |